AXQ Capital’s Regenxbio RGNX Stock Holding History

AXQ Capital’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221K	Buy	+18,446	New	+$153K	0.02%	699
2025 Q1	–	Sell	-13,732	Closed	-$106K	–	659
2024 Q4	$106K	Buy	+13,732	New	+$129K	0.05%	376

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AXQ Capital's RGNX Position: Q2 2026 in Review

AXQ Capital opened a new position in Regenxbio (RGNX) in Q2 2026: 18,446 shares worth $221K. The stake represents 0.02% of the portfolio and ranks #699 among its holdings. This is a return to the name: AXQ Capital previously reported a position in RGNX as recently as Q4 2024.

AXQ Capital first reported a position in RGNX in Q4 2024 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

AXQ Capital held 18,446 shares of Regenxbio worth $221K as of Q2 2026.
Regenxbio was a new AXQ Capital position in Q2 2026.
Regenxbio made up 0.02% of AXQ Capital's portfolio in Q2 2026, its #699 holding.
AXQ Capital first reported a position in Regenxbio in Q4 2024 and has held it in 2 quarters since.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.